FDA Recall Terminated Historical recordClass II
OFLOXACIN 0.3% 5ML OPTH; NDC/UPC 17478071310; RX; DROPS
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
Cardinal Health Inc.
Recalls
A bar chart of the number of recalls naming this company by year.
| Year | Recalls |
|---|---|
| 2021 | 86 |
| 2022 | 3 |
| 2023 | 6 |
| 2025 | 5 |
FDA Recall Terminated Historical recordClass II
FENOFIBRATE CAPSULES, UPS 67MG 100 CAPSULES NDC/UPC 27241-118-04; RX; CAPSULES
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
FDA Recall Terminated Historical recordClass II
METHOCARBAMOL 500MG 500; NDC/UPC 71093014005; RX; TABLETS
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
FDA Recall Terminated Historical recordClass II
Norvir Ritonavir Tablets 100 mg 30 Tablets Rx only NDC 0074-3333-30 Abbott Laboratories North Chicago, IL 60064, U.S.A.
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
FDA Recall Terminated Historical recordClass II
Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodium, 28 Tablets For 28 Days Rx only NDC 0074-0038-28 Each carton contains 28 tablets in 4 weekly blister pack, Each weekly blister pack contains 7 tablets of elagolix 150 mg AbbVie Inc. North Chicago, IL 60064
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
FDA Recall Terminated Historical recordClass II
Creon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDC 0032-3016-13 100 Capsules Marketed by: AbbVie Inc. North Chicago, IL 60064, U.S.A.
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
FDA Recall Terminated Historical recordClass II
NIACIN 250MG 110; NDC/UPC 740985228494; OTC; TABLETS
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
FDA Recall Terminated Historical recordClass II
THERAPEUTIC M 130; NDC/UPC 740985223680; OTC; TABLETS
- Reason
- CGMP Deviations: Intermittent exposure to temperature excursion during storage.
- Published
- June 2, 2021
- Distribution
- Multiple states
FDA Recall Terminated Historical recordClass III
Tremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044; NDC 57894-640-01.
- Reason
- Temperature Abuse
- Published
- April 7, 2021
- Distribution
- Multiple states
This page lists recalls that name Cardinal Health Inc. as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.
